Boyu Capital

Boyu Capital is a private equity firm that invests in consumer, retail, media and technology, healthcare, and financial services sectors.

Business Model: B2C

Revenue: $5M

Employees: 11-50

Rankings

Detailed Boyu Capital Information

Geographic Data

Boyu Capital headquarters map

Address: 88 Queensway

City: Hong Kong

State: other

Zip:

Country: HK

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$4B

Metrics

8,278,836Website Global Rank

340Website Monthly Traffic

Twitter Followers

Description

Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China. Boyu Capital Consultancy Co. Ltd was founded on September 28, 2010 and is based in Hong Kong with an additional office in Beijing, China.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
6/2014 COFCO Post-IPO Equity -
12/2022 ArriVent Biopharma Series B 0
11/2020 D3 Bio Series A 200M
6/2022 Evat Master Series A 0
12/2021 Jinke Post-IPO Equity 478.6M
2/2014 LY.com Series C 82.3M
7/2016 CStone Pharmaceuticals Series A 150M
8/2018 KLOOK Series D 200M
8/2021 MediTrust Health Series C 308.3M
12/2021 Recurrent.ai Venture Round 38M
7/2020 Antengene Corporation Series C 97M
11/2018 NetEase Cloud Music Series B 600M
12/2019 Kuaishou Technology Series F 3B
8/2021 Zeekr Series A 500M
7/2018 Trax Series D 0
11/2021 J&a;T Express Private Equity Round 0
8/2020 Yuanfudao Series G 1.2B
2/2018 Viela Bio Series A 0
11/2021 Vision Medicals Series D 47M
2/2017 iQiyi Series G 1.5B
7/2018 Curon Biopharma Series A 150M
7/2018 MEGVII Series D -
9/2021 XSKY Data Technology Series E 0
8/2021 Pulse Medical Technology Series C 0
9/2018 LianLian Pay Venture Round 146.6M
3/2022 MoreSec Series D 0
5/2022 Shuaike Pet Food Products Private Equity Round 0
6/2021 RecBio Series C 156.3M
1/2021 KLOOK Series E 0
9/2017 LifeMine Therapeutics Series A 0
11/2017 Berry Oncology Series A 121.2M
9/2019 Chengjia Apartment Series A 300M
12/2020 SciNeuro Series A 100M
4/2021 J&a;T Express Private Equity Round 2B
5/2013 Berry Genomics Series B 14.7M
8/2021 MediTrust Health Series C 0
5/2018 China Chengxin Credit Series A 0
10/2021 WT Microtech Medical Series E 153M
1/2019 Yimidida Series D 266.1M
9/2012 Alibaba Group Private Equity Round 0
5/2018 Brii Biosciences Venture Round 260M
3/2020 Yuanfudao Series G 1B
3/2020 Pinduoduo Post-IPO Equity 1.1B
6/2019 Waterdrop Series C 144.6M
4/2021 Adcentrx Therapeutics Series A 50M
9/2022 Animoca Brands Convertible Note 110M
5/2018 CStone Pharmaceuticals Series B 260M
3/2020 Yatsen Holding Series D 240M
11/2021 Positive Sequence Biology Series A 0
6/2022 Frontera Therapeutics Series B 0
2/2022 ArriVent Biopharma Series A 69M
1/2021 4Paradigm Series D 0
1/2021 Lalamove Series F 1.5B
11/2021 Edge Medical Robotics Series C 0
1/2019 Antengene Corporation Series B 0
8/2021 Abogen Biosciences Series C 0
6/2021 ArriVent Biopharma Series A 81M
6/2022 Frontera Therapeutics Series B 0
6/2022 Evat Master Series A 0
5/2022 Shuaike Pet Food Products Private Equity Round 0
3/2022 MoreSec Series D 0
2/2022 ArriVent Biopharma Series A 0
12/2021 Recurrent.ai Venture Round 0
12/2021 Jinke Post-IPO Equity 0
11/2021 Vision Medicals Series D 0
11/2021 J&a;T Express Private Equity Round 0
11/2021 Positive Sequence Biology Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research